How have NTRB shares performed in 2024?

Nutriband's stock was trading at $2.32 at the beginning of 2024. Since then, NTRB shares have increased by 74.1% and is now trading at $4.04. View the best growth stocks for 2024 here .

Are investors shorting Nutriband?

Nutriband saw a increase in short interest in March. As of March 31st, there was short interest totaling 36,300 shares, an increase of 1,412.5% from the March 15th total of 2,400 shares. Based on an average daily trading volume, of 41,900 shares, the short-interest ratio is presently 0.9 days. Approximately 1.0% of the company's shares are sold short. View Nutriband's Short Interest .

When is Nutriband's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024. View our NTRB earnings forecast .

How were Nutriband's earnings last quarter?

Nutriband Inc. (NASDAQ:NTRB) announced its quarterly earnings data on Monday, December, 13th. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.11. The company had revenue of $0.28 million for the quarter, compared to the consensus estimate of $0.50 million. Nutriband had a negative trailing twelve-month return on equity of 73.13% and a negative net margin of 252.90%.

When did Nutriband's stock split?

Shares of Nutriband split before market open on Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were issued to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

How do I buy shares of Nutriband?

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

→ Your Money is Not Safe (From American Alternative) (Ad)

Free NTRB Stock Alerts

$4.04

-0.23 (-5.39%)

(As of 04/18/2024 ET)

Compare

Today's Range: $4.00
▼
$4.25
50-Day Range: $2.30
▼
$5.06
52-Week Range: $1.53
▼
$5.93

Volume: 24,004 shs
Average Volume: 39,182 shs
Market Capitalization: $31.63 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Nutriband alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Nutriband Stock (NASDAQ:NTRB)

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

NTRB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NTRB Stock News Headlines

April 1, 2024 | finance.yahoo.com

Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance

March 28, 2024 | marketwatch.com

Nutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA Submission

April 18, 2024 | American Alternative (Ad)

Your Money is Not Safe

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

March 27, 2024 | benzinga.com

Gerald Goodman's Net Worth

March 27, 2024 | finanznachrichten.de

Nutriband Inc.: Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA Fentanyl Transdermal Patch

March 27, 2024 | finance.yahoo.com

Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch

January 29, 2024 | finance.yahoo.com

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

January 26, 2024 | finanznachrichten.de

Nutriband Inc.: Nutriband CEO Publishes Letter to Shareholders

April 18, 2024 | American Alternative (Ad)

Your Money is Not Safe

January 26, 2024 | finance.yahoo.com

Nutriband CEO Publishes Letter to Shareholders

January 5, 2024 | finance.yahoo.com

Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch

December 29, 2023 | morningstar.com

Nutriband Inc NTRB

December 18, 2023 | investorplace.com

NTRB Stock Earnings: Nutriband Reported Results for Q3 2023

November 28, 2023 | finance.yahoo.com

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

November 28, 2023 | finance.yahoo.com

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

October 11, 2023 | finance.yahoo.com

Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

September 20, 2023 | finanznachrichten.de

Financialnewsmedia.com: Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

September 20, 2023 | finanznachrichten.de

Nutriband Inc.: Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

September 20, 2023 | finance.yahoo.com

Nutriband Unveils Groundbreaking Innovation in Transdermal Medications

September 20, 2023 | finance.yahoo.com

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

September 12, 2023 | finance.yahoo.com

Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

September 11, 2023 | finance.yahoo.com

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

August 30, 2023 | finance.yahoo.com

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

July 28, 2023 | marketwatch.com

Nutriband Shares Rise 16% After Launch of New Medical Tape Product

July 27, 2023 | finance.yahoo.com

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

July 14, 2023 | finanznachrichten.de

Nutriband Inc.: Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA Platform Towards FDA Submission

July 14, 2023 | marketwatch.com

Nutriband Shares Rise 14% After Credit Line Increased to Fund Fentanyl Deterrent Tech

See More Headlines

Receive NTRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 12/13/2021
Today: 4/18/2024
Next Earnings (Estimated): 4/24/2024
Fiscal Year End: 1/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NASDAQ:NTRB
CUSIP: N/A
CIK: 1676047
Web: nutriband.com
Phone: (407) 377-6695
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.67)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,480,000.00
Net Margins: -252.90%
Pretax Margin: -252.90%
Return on Equity: -73.13%
Return on Assets: -57.85%

Debt

Debt-to-Equity Ratio: 0.37
Current Ratio: 2.79
Quick Ratio: 2.54

Sales & Book Value

Annual Sales: $2.08 million
Price / Sales: 16.11
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.09 per share
Price / Book: 3.93

Miscellaneous

Outstanding Shares: 7,830,000
Free Float: 4,453,000
Market Cap: $33.51 million
Optionable: Not Optionable
Beta: 0.86

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Serguei Melnik (Age 50)
Founder, President, Company Secretary & Executive Chairman of the Board
Comp: $200k
Mr. Gareth Sheridan (Age 34)
Founder, CEO & Director
Comp: $200k
Mr. Gerald Goodman (Age 76)
CFO & Chief Accounting Officer
Comp: $160k
Dr. Alan Smith Ph.D. (Age 58)
COO & President of 4P Therapeutics
Comp: $179k
Mr. Patrick Ryan (Age 38)
Chief Technical Officer
Dr. Jeffrey Patrick Pharm.D. (Age 54)
Chief Scientific Officer
Mr. Tyler Overk (Age 40)
President of Active Intelligence

Key Competitors

View All Competitors

Institutional Ownership

AlphaQ Advisors LLC
Sold 5,834 shares on 1/29/2024
Ownership: 0.149%

View All Institutional Transactions

NTRB Stock Analysis - Frequently Asked Questions

How have NTRB shares performed in 2024?: Nutriband's stock was trading at $2.32 at the beginning of 2024. Since then, NTRB shares have increased by 74.1% and is now trading at $4.04.
View the best growth stocks for 2024 here.
Are investors shorting Nutriband?: Nutriband saw a increase in short interest in March. As of March 31st, there was short interest totaling 36,300 shares, an increase of 1,412.5% from the March 15th total of 2,400 shares. Based on an average daily trading volume, of 41,900 shares, the short-interest ratio is presently 0.9 days. Approximately 1.0% of the company's shares are sold short.
View Nutriband's Short Interest.
When is Nutriband's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our NTRB earnings forecast.
How were Nutriband's earnings last quarter?: Nutriband Inc. (NASDAQ:NTRB) announced its quarterly earnings data on Monday, December, 13th. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.11. The company had revenue of $0.28 million for the quarter, compared to the consensus estimate of $0.50 million. Nutriband had a negative trailing twelve-month return on equity of 73.13% and a negative net margin of 252.90%.

When did Nutriband's stock split?: Shares of Nutriband split before market open on Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were issued to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.
How do I buy shares of Nutriband?: Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NTRB) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial